STARD13 Antikörper (N-Term)

Produktnummer ABIN7184505

Der Kaninchen Polyklonal Anti-STARD13-Antikörper wurde für ELISA, WB und IF validiert. Er ist geeignet, STARD13 in Proben von Human zu detektieren.

Kurzübersicht für STARD13 Antikörper (N-Term) (ABIN7184505)

Target: STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser STARD13 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Immunofluorescence (IF)

Produktdetails anti-STARD13 Antikörper

Bindungsspezifität: N-Term

Kreuzreaktivität: Human

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from N-terminal of Human STA13.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB:1:500-1:3000, IF:1:100-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu STARD13

Target: STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))

Andere Bezeichnung: STARD13

Hintergrund:

Background: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells.

Ching Y.-P., J. Biol. Chem. 278:10824-10830(2003).
Nagaraja G.M., Biochem. Biophys. Res. Commun. 313:654-665(2004).
Leung T.H.-Y., Proc. Natl. Acad. Sci. U.S.A. 102:15207-15212(2005).

Aliases: 46H23.2 antibody, ARHGAP37 antibody, Deleted in liver cancer 2 protein antibody, Deleted in liver cancer protein 2 antibody, DLC-2 antibody, DLC2 antibody, GT650 antibody, Rho GTPase activating protein on chromosome 13q12 antibody, Rho GTPase-activating protein antibody, STA13 antibody, STA13_HUMAN antibody, StAR related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer protein 13 antibody, StARD13 antibody, START domain-containing protein 13 antibody

UniProt: Q9Y3M8